Supplementary Data from Selinexor Combined with Ibrutinib Demonstrates Tolerability and Safety in Advanced B-Cell Malignancies: A Phase I Study
Authors:
- Deborah M. StephensDSDeborah M. Stephens
- Ying HuangYHYing Huang
- Amy S. RuppertARAmy S. Ruppert
- Janek S. WalkerJWJanek S. Walker
- Daniel CanfieldDCDaniel Canfield
- Casey B. CempreCCCasey B. Cempre
- Qiang FuQFQiang Fu
- Sharyn BakerSBSharyn Baker
- Boyu HuBHBoyu Hu
- Harsh ShahHSHarsh Shah
- Renee VadeboncoeurRVRenee Vadeboncoeur
- Kerry A. RogersKRKerry A. Rogers
Open Access
- 31 March 2023
- other
- Published by American Association for Cancer Research (AACR)